Oslo, Norway

Auden Tornes


Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 102(Granted Patents)


Company Filing History:


Years Active: 2003-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **The Innovative Mind of Auden Tornes**

Introduction

Auden Tornes is a prominent inventor based in Oslo, Norway. He has made significant contributions to the field of brachytherapy, securing a total of two patents that enhance the effectiveness and safety of this medical treatment.

Latest Patents

Auden's latest patents focus on products and methods for brachytherapy, specifically radioactive sources such as seeds designed for clinical use. These inventions incorporate a radioisotope contained within a sealed biocompatible container. Notably, at least one part of the container's surface is treated to ensure it is not smooth. This surface treatment is engineered to improve the ultrasound visibility of the source, which is essential for accurate placement in a patient's body. Furthermore, the modifications help reduce the likelihood of the source migrating post-implantation. The preferred radioisotopes employed in these innovations are palladium-103 and iodine-125.

Career Highlights

Auden serves at Amersham Plc, where he leverages his expertise in medical technologies and innovations. His work has not only advanced the field of brachytherapy but has also had a positive impact on patient outcomes through improved treatment methodologies.

Collaborations

Throughout his career, Auden has collaborated with esteemed colleagues such as Gregory L. McIntire and Robert A. Snow. These partnerships have facilitated the development of cutting-edge technologies and have contributed to the successful execution of his patented inventions.

Conclusion

Auden Tornes stands out as an influential inventor in the realm of brachytherapy. His innovative approaches and dedication to enhancing medical treatments showcase the importance of creativity and research in the field of health care. Through his continued work at Amersham Plc, he remains committed to developing technologies that make a difference in patients' lives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…